Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9548519rdf:typepubmed:Citationlld:pubmed
pubmed-article:9548519lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0011065lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0699040lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0023690lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0253023lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C1332714lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:9548519lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:9548519pubmed:issue11lld:pubmed
pubmed-article:9548519pubmed:dateCreated1998-4-20lld:pubmed
pubmed-article:9548519pubmed:abstractTextCross-linking of cell surface CD4 molecules by anti-CD4 mAb or HIV-1 gp120/anti-gp120 Ab primes resting T lymphocytes for activation-induced cell death (AICD) triggered via the CD3/TCR complex. In striking contrast, we demonstrate here that preincubation of activated human CD4+ T cells with anti-CD4 mAb consistently inhibited AICD triggered via anti-CD3 mAb or Staphylococcus aureus enterotoxin A superantigen. Inhibition of AICD of CD4+ T cell clones was also observed with F(ab')2, but not with Fab, of anti-CD4 mAb. Moreover, soluble HIV-1 gp120, but not rIL-16, inhibited AICD stimulated by S. aureus enterotoxin A. In susceptible clones, CD4 ligation prevented the up-regulation of Fas ligand mRNA and cell surface expression in response to anti-CD3 mAb or superantigen stimulation. CD3/TCR-dependent protein tyrosine phosphorylation and cytokine production were also prevented by preceding CD4 ligation. The inhibition of AICD due to the prevention of Fas ligand upregulation reveals a novel immunoregulatory consequence of CD4 ligation that might play a role in HIV infection and in the therapeutic application of anti-CD4 mAb.lld:pubmed
pubmed-article:9548519pubmed:languageenglld:pubmed
pubmed-article:9548519pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9548519pubmed:statusMEDLINElld:pubmed
pubmed-article:9548519pubmed:monthDeclld:pubmed
pubmed-article:9548519pubmed:issn0022-1767lld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:KabelitzDDlld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:ObergH HHHlld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:JanssenOOlld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:DobmeyerTTlld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:Lengl-Janssen...lld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:FlindtSSlld:pubmed
pubmed-article:9548519pubmed:authorpubmed-author:SanzenbacherR...lld:pubmed
pubmed-article:9548519pubmed:issnTypePrintlld:pubmed
pubmed-article:9548519pubmed:day1lld:pubmed
pubmed-article:9548519pubmed:volume159lld:pubmed
pubmed-article:9548519pubmed:ownerNLMlld:pubmed
pubmed-article:9548519pubmed:authorsCompleteYlld:pubmed
pubmed-article:9548519pubmed:pagination5742-9lld:pubmed
pubmed-article:9548519pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:meshHeadingpubmed-meshheading:9548519-...lld:pubmed
pubmed-article:9548519pubmed:year1997lld:pubmed
pubmed-article:9548519pubmed:articleTitleLigation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression.lld:pubmed
pubmed-article:9548519pubmed:affiliationDepartment of Immunology, Paul Ehrlich Institute, Langen, Germany.lld:pubmed
pubmed-article:9548519pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9548519lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9548519lld:pubmed